As of 2026-06-21, the Relative Valuation of Talaris Therapeutics Inc (TALS) is (33.67) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.72 USD, the upside of Talaris Therapeutics Inc based on Relative Valuation is -1337.7%.
The range of the Relative Valuation is (32.31) - (36.16) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.7x - 21.2x | 19.0x |
| Forward P/E multiples | 18.5x - 20.7x | 19.6x |
| Fair Price | (32.31) - (36.16) | (33.67) |
| Upside | -1288.0% - -1429.3% | -1337.7% |
| Date | P/E |